- Report
- October 2024
- 70 Pages
France
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Germany
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
India
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €865EUR$950USD£734GBP
- Report
- March 2025
- 89 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Global
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
North America
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Asia Pacific
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Europe
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Japan
From €865EUR$950USD£734GBP
- Report
- December 2023
- 132 Pages
Global
From €865EUR$950USD£734GBP
The Anastomosis Assist Device (AAD) market is a subset of the larger Surgical Devices market. AADs are used to facilitate the connection of two blood vessels or hollow organs during a surgical procedure. AADs are designed to reduce the time and complexity of the procedure, as well as reduce the risk of complications. AADs are typically used in vascular, gastrointestinal, and thoracic surgeries.
AADs are typically composed of a handle, a shaft, and a cutting blade. The handle is used to control the device, while the shaft and blade are used to cut and connect the vessels or organs. AADs are available in a variety of sizes and shapes, depending on the type of surgery being performed.
The AAD market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Medtronic, Johnson & Johnson, Stryker, and B. Braun. Show Less Read more